NAKA — Nakamoto Inc
NASDAQ · Health Care · Health Care
- Latest Close
- $0.23
- 30-Day Move
- -40.6%
- Market Cap
- $149M
- Shares Outstanding
- 683,450,000
- P/B Ratio
- 3.34
- ROE
- -140.9%
Nakamoto Inc
A read-only Alphactor snapshot forNakamoto Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-23
Topline snapshot
Latest Close
$0.23
30-Day Move
-40.6%
Market Cap
$149M
Shares Outstanding
683,450,000
P/B Ratio
3.34
ROE
-140.9%
$0.23
-40.6%last 90 delayed daily bars
90D High
$0.52
90D Low
$0.21
Avg Volume
6,321,473
Gross margin is running at 98.8%, which gives a quick read on operating quality before you open the full model.
Net margin is -4569.5%, useful for comparing NAKA against peers in Health Care.
NAKA is down 40.6% over the last 30 trading days shown on this page.
Latest operating income is $-21M, which helps anchor the headline ratios with an actual earnings figure.
Rule of 40
-39564.5%
Latest Close
$0.23
30-Day Move
-40.6%
Market Cap
$149M
Shares Outstanding
683,450,000
P/B Ratio
3.34
ROE
-140.9%
ROA
-98.4%
Gross Margin
98.8%
Operating Margin
-4497.8%
Net Margin
-4569.5%
Debt / Equity
0.06
Current Ratio
4.13
Latest Revenue
$2M
Revenue
$2M
Gross Profit
$-9M
Operating Income
$-21M
Net Income
$-52M
Gross Margin
9885.0%
Net Margin
-456949.0%
Current Ratio
4.13
Debt / Equity
0.06
Altman Z
0.22
Distress
Piotroski
2
Weak (0-3)
Cash Conversion
0.45x
Rule of 40
-39564.5%
Concerning
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $4M | $-3M | $-3M | $-457,771 |
| 2023-12-31 | $4M | $-2M | $-2M | $-463,909 |
| 2024-12-31 | $3M | $-3M | $-4M | $-3M |
| 2025-12-31 | $2M | $-21M | $-52M | $-720M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
FMR LLC (Fidelity)
Filed 2026-02-17
--
--
Vanguard Group
Filed 2025-11-07
$6M
+32737.0%
Geode Capital Management
Filed 2025-11-12
$5M
+21606.8%
Renaissance Technologies
Filed 2025-11-13
$3M
--
Citadel Advisors
Filed 2025-11-14
$3M
--
Charles Schwab
Filed 2025-11-10
$2M
--
Northern Trust
Filed 2025-11-14
$819,574
+3322.8%
Goldman Sachs
Filed 2026-02-10
$743,262
--
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Healthcare Investing: Pharma, Biotech, and the FDA Calendar
A framework for navigating healthcare stocks across pharma, biotech, and medical devices, with emphasis on regulatory catalysts and pipeline valuation.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.